Skip to main content
Premium Trial:

Request an Annual Quote

And You Just Couldn't Delete Those "V1agra" E-mails Fast Enough

At the Microarray Blog today, Paul Albin has a post about how an anti-spam algorithm developed at IBM is now being put through the paces to see if it can help detect and block rapidly evolving mutations in HIV. In a partnership fostered by Bill Gates, AIDS researcher David Heckerman has teamed up with the anti-spam group at Microsoft Research in an effort to help "find drugs for HIV," according to Albin. The post links out to a video from Microsoft detailing the research.

While the work sounds really interesting, GTO just hopes that any drugs coming out of the work are more effective at combating HIV than the typical Microsoft product is at combating spam.

 

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.